Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

AnaptysBio Inc buy BTIG Research

Start price
€24.80
26.02.24 / 50%
Target price
€50.64
26.02.25
Performance (%)
-3.23%
Price
€24.00
07.05.24
Summary
This prediction is currently active. With a performance of -3.23%, the BUY prediction for AnaptysBio Inc by BTIG_Research is down slightly. This prediction currently runs until 26.02.25. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
AnaptysBio Inc 3.509% 3.509%
iShares Core DAX® 2.831% 1.236%
iShares Nasdaq 100 2.918% 0.640%
iShares Nikkei 225® 2.007% -2.135%
iShares S&P 500 2.257% 0.451%

Comments by BTIG_Research for this prediction

In the thread AnaptysBio Inc diskutieren
Prediction Buy
Perf. (%) -3.23%
Target price 50.644
Change
Ends at 26.02.25

AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at BTIG Research. They set a "buy" rating and a $55.00 price target on the stock.
Ratings data for ANAB provided by MarketBeat